A pioneering trial in China, led by a team from Nankai University, has marked the nation's inaugural successful application of an interventional brain-computer interface. This groundbreaking technology was designed to aid in the restoration of motor function in the affected limbs of the human body. Through this endeavor, a hemiplegic patient was successfully assisted in regaining partial motor function. The mechanism behind this technology involves the collection of brain electrical signals via a minimally invasive surgical procedure performed on the cervical blood vessels. Currently, multi-center clinical trials have commenced, heralding a promising future where this technology could offer a novel therapeutic avenue for patients grappling with motor dysfunction. China's brain-computer interface technology landscape is experiencing rapid growth, bolstered by the introduction of multiple policies and standards. A case in point is the "Terminology for Medical Devices Utilizing Brain-Computer Interface Technology," which is slated for official implementation on January 1, 2026. Furthermore, in August of this year, seven governmental departments jointly issued implementation guidelines. These guidelines explicitly outline that by 2027, key technological breakthroughs should be achieved, and by 2030, the industry's capacity for innovation should witness a substantial enhancement, with its overall prowess ascending to the global forefront.